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Introduction 20 The development of efficient drug delivery systems represents an important challenge to deal with issues such as drug solubility, targeting, in vivo stability, clearance, and cytotoxicity. [1] [2] [3] [4] [5] [6] Nanotechnology-based drug delivery systems are suitable candidates to overcome the need for innovative delivery, 25 bioavailability of hydrophobic drugs, high drug payload, extended drug half-life, improved therapeutic index, and controlled release with reduced immunogenicity and toxicity. [7] [8] [9] [10] [11] A primary challenge to define the full promise of nanoparticlesbased drug delivery is the lack of optimal strategies to achieve a 30 selective and efficient cellular targeting. [12] [13] [14] The mechanism of nanoparticles uptake is dependent on many variables including the particle size, shape, outer surface composition, and the targeting approach used. [15] [16] [17] [18] Typically, the targeting strategies are classified as passive 35 (commonly referred to the EPR effect) [19] [20] or active. In both cases, when the cellular target is extravascular, the carrier (if administered systemically) needs to cross the endothelium, whose permeability is normally increased by the occurrence of the disease. One of the most important issues associated with the 40 active targeting deals with the high selectivity with which the carrier must recognize the cellular target. This step is often the crucial one in defining the therapeutic index of a drug. In almost all the pathologies, the lesions are quite heterogeneous, and different cell populations are present, thus often jeopardizing the 45 selectivity. A possible solution can be envisaged for specific target cells. A representative example is offered by the bone marrow-derived blood-circulating cells of the immune system that have a pivotal role in both, acute/chronic and regenerative, cellular phases of inflammation. Such cells are mainly 50 represented by monocytes/macrophages and neutrophils, both displaying phagocytic activity. These cells are recruited by inflammation sites to modulate the inflammatory response. In particular, the infiltrated monocytes exert their effect after differentiating in macrophages. 55 As inflammation is a common process in many diseases, targeting circulating monocytes/macrophages and using them as "Trojan Horses" to deliver drugs to treat (or diagnose by in vivo imaging modalities) diseases with a high grade of inflammation (e.g. arthritis, atherosclerosis, some cancers, neurodegenerative 60 diseases) may be a valuable approach to deliver diagnostic/therapeutic agents in a specific way. By virtue of the growing interest to design improved delivery systems for targeting macrophages 21 , labelling blood-circulating monocytes could be a feasible approach to achieve this goal.
whereas others are based on nanosystems that can be phagocytized in vivo. [25] [26] However, in both cases the targeting agent can itself distribute in the inflamed lesion due to the associated leaky endothelium, thus reducing the macrophage targeting selectivity. Negative 5 outcomes could be the diminution of the therapeutic index in case of a drug, whereas for a diagnostic agent, the extravasation of the free imaging probe may bias the outcome of the procedure owing to the generation of a unspecific signal due to the non cellinternalized agent and/or to the agent taken up by cells in situ, 10 thereby not reporting on cell recruitment. A possible solution to this issue, is the use of a carrier that can target circulating monocytes/macrophages, but is unable to cross the leaky endothelium. In such a way, the therapeutic/diagnostic agent will be guided into the lesion by circulating cells only. 15 We surmised that Glucan Particles (GPs) were potential candidates to achieve this goal. GPs are porous, hollow microspheres that are prepared from Saccharomyces Cerevisiae (baker's yeast). 27 They are composed of 1,3-Beta-D-glucan and trace amounts of chitin and have an average diameter of 2-3 20 microns that prevent them to pass through leaky endothelium. 19, [27] [28] [29] 1,3-β-D-glucan acts as a strong ligand for receptor-mediated phagocytosis of monocytes/macrophages (as well as dendritic cells) expressing β-glucan receptors (dectin-1 receptor (D1) and 25 complement receptor 3 (CR3)). 27, [29] [30] [31] [32] [33] GPs uptake has been demonstrated to be dectin-1 dependent in vitro. [34] [35] [36] [37] [38] The ability of GPs to serve as carrier relies upon the possibility to fill up the cavity with chemicals with different physico-chemical properties. In fact, procedures for the encapsulation of charged 30 macromolecules, amphiphilic or lipophilic molecules, and also hydrophilic small-sized chemicals (through their preencapsulation in liposomes) have been developed. 29, [39] [40] [41] Though not yet reported, the peculiar properties of GPs could be exploited to entrap both a therapeutic and a diagnostic agent. We reported 35 that a macrophage population labelled ex-vivo with Gd-loaded GPs and then i.v. injected in a mouse model of acute liver inflammation allowed the MRI visualization of the macrophage recruitment in the inflamed region. 42 Differently, the motivation of this work was to test the feasibility 40 of the approach consisting of labeling monocytes/macrophages in vivo (e.g. after i.v. injection of GPs), and tracking their migration in the inflammation site by Near InfraRed Fluorescence (NIRF) imaging. It has been demonstrated in some recent examples that this 45 imaging technique has the potential to allow the detection of immune cells labeled/targeted with fluorescent dyes. [43] [44] [45] [46] NIR fluorophores work in the spectrum of 700 to 900 nm, where the light absorption by tissue chromophores is minimal, thus reducing background interferences. 47-50 50 We loaded GPs with two water insoluble fluorescent dyes: one, Cy-5(C16) 2 , based on cyanine fluorophore, for NIRF imaging, and the other, Rho-DOPE (commercially available), based on rhodamine structure for ex-vivo microscopy validation. The particles were tested in vivo on an autoimmune model of 55 rheumatoid arthritis in mice (Collagen Induced Arthritis, CIA), which is a widely used model of arthritis induced by immunization with an emulsion of complete Freund's adjuvant and type II collagen (CII). 51 This model is mainly characterized by proliferative synovitis with acute and chronic infiltration of 60 polymorphonuclear and mononuclear cells, pannus formation, and fibrosis. [52] [53] [54] [55] The mononuclear cell infiltration that characterizes the chronic inflammatory reaction results from the migration of lymphocytes and monocytes through the vascular endothelium. 54 Furthermore, this model is very suitable for the 65 purposes of this work, either because the lesions are superficial (thus overcoming the limited tissue penetration of NIRF) or for the extensive recruitment of immune cells. The success of labeling phagocytic cells in vivo with imaging agents could open the way to new macrophage-targeted drug delivery to 70 attenuate/suppress inflammatory processes, where the effective delivery of the drug can be visualized through the coencapsulation of the imaging agent and the therapeutic drug (theranostic approach). 24,56 75 
Materials and Methods

Chemicals
All reagents and solvents, unless otherwise indicated, were purchased from Sigma-Aldrich (Milano, Italy). The cyaninebased fluorescent probe (Cy5-(C 16 ) 2 ) was synthesized following a 80 previously reported procedure. 57
Animal Model
Male DBA/1J mice, 7-9 weeks of age and free of murine-specific pathogens, were purchased from Harlan (Harlan Italy, San Pietro 85 al Natisone (UD)). To induce CIA, mice were immunized intradermally at the base of the tail with 0.2 ml of an emulsion containing 0.4 mg of bovine type II collagen (Morwell Diagnostics, Zurich, Switzerland) in Complete Freund's Adjuvant (CFA, Difco, Detroit, U.S.A.) containing 0.4 mg of 90 Mycobacterium tuberculosis. Immunization with CFA+CII resulted, starting approximately from day 18-20 p.i., in the appearance of signs of inflammation affecting one or more limbs. The number of arthritic limbs were quantitated and each limb assigned a severity score according to the criteria reported 95 elsewhere. 58 All the procedures involving mice were conducted in agreement with Italian and European guidelines and policies on animal testing, and were approved by the local animal experiments ethical committee. 100 
Preparation and characterization of Glucan Particles
According to a previously reported procedure, 27 Saccharomyces Cerevisiae were suspended in 1 M NaOH solution and heated at 80°C for 1 h under continuous magnetic stirring. The insoluble material was then collected by centrifugation and suspended in 105 acidic water (pH 5) and stirred for 1h at 55°C. The insoluble material was collected again by centrifugation and washed in water, isopropanol and then acetone. The product obtained was dried at room temperature to a fine powder. The so-obtained dry glucan particles (100 mg) were incubated overnight at 20°C with 110 2 mL of a chloroform solution containing Cy5-(C16) 2 (50 µg/mL corresponding to 37.0 µM) and 1,2-dioleoyl-sn-glycero-3phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhodamine-DOPE) (50 µg/mL corresponding to 38.5 µM) (Avanti ® Polar Lipids, Inc. Alabaster, Alabama, 115 USA). The resulting labeled particles (Cy5-(C16) 2 /Rho-GPs) were washed four times in HEPES Isotonic Buffer, re-suspended in the same buffer and counted with the haemocytometer. To characterize the microcarrier obtained, IR spectroscopy and Atomic Force Microscopy (AFM) were used (see ESI †). The excitation and emission spectra were acquired with a 5 spectrofluorometer (Fluoromax-4-Horiba Scientific). The concentration of entrapped Rho-DOPE and Cy5(C16) 2 , respectively, were calculated using a spectrophotometer (Hitachi U-28000), according to calibration curves previously prepared from standard solutions (see ESI †). Drug Loading Content (DLC) 10 and Drug Loading Efficiency (DLE) for the two dyes in Glucan Particles were estimated as follows:
The suspension of Cy5-(C16) 2 /Rho-GPs was then analysed by means of confocal microscopy to check the double fluorescence 15 labelling with Cyanine-and Rhodamine-based dyes (laser 1 excitation 561 nm, acquisition window 571-644 nm, laser 2 excitation 633 nm, acquisition window 650-720 nm). To verify the detection sensitivity of the system, different concentrations of Cy5-(C16) 2 /Rho-GPs were imaged using a Pearl Imager (Near- 20 infrared In Vivo Animal Imaging System, LI-COR Biosciences-Lincoln, Nebraska, USA, λ exc 685 nm -λ em 720 nm). More in details, particles were counted with the hemocytometer and then diluted in PBS at different concentrations ranging from 18x10 6 the labelling efficiency of GPs toward phagocytic cells, confocal microscopy, Fluorescence Activated Cell Sorting (FACS) analysis and Optical Imaging of cells incubated with Cy5-(C16) 2 /Rho-GPs were performed (see ESI †). For Optical Imaging 55 2x10 6 J774A.1 cells were seeded into T75 tissue flasks and left in complete DMEM for 48h at 37°C in a humidified 5% CO 2 atmosphere. The medium was then discarded, and cells were incubated with 350 µl of Cy5-(C16) 2 /Rho-GPs in 5 ml of complete medium (5.95x10 5 GPs/µL DMEM corresponding to 60 3.20 μM of Cy5-(C16) 2 and 3.85 μM of Rho-DOPE) for 90 min. Afterwards, cells were washed four times in Phosphate Buffered Saline (PBS), harvested, counted with the haemocytometer, and centrifuged. The pellet was then suspended in PBS at different concentrations from 20000 down to 300 cells/µl. PBS was used 65 as control. The samples obtained were then analysed under the Pearl Imager to evaluate the detection sensitivity of the system. To evaluate the limit of detection, a ROI was drawn around each sample and the signal intensity was calculated. SI/S0 was determined as reported in paragraph "Preparation of Glucan where the subscript postCIA refers to the signal detected on CIAaffected mice, and postNAIVE is the corresponding signal measured on naïve mice. 90 
Histochemistry and Immunofluorescence
Naïve and CIA-affected DBA/1 mice were sacrificed 3h p.i. of Cy5-(C16) 2 /Rho-GPs. Fore and hind legs were excised and left 48 hours in formalin at 4°C, in rotation. The day after, formalin 95 was removed, the legs were washed with PBS, and decalcified at room temperature in a 1:1 solution A (2.5 g Sodium citrate tribasic dehydrate dissolved in 125 mL of distilled water and 102.5 mL of tap water) and B (147.5 mL of Formic Acid 96% diluted in 102.5 mL of distilled water). When the process was 100 completed, sagittal and coronal sections of fore and hind legs were carved. The sections obtained were cryo-preserved in Optimum Cutting Temperature (O.C.T.) compound (VWR International) (5 min in liquid nitrogen before cooling down to -80°C). Slices (thickness 5 µm) were cut using a cryostat (Leica 105 CM 1950). Three sections from the center of naïve and CIA affected mice paws were stained with Hematoxylin and Eosin (H&E). Other three sections were stained with Periodic acid-Schiff (PAS) to highlight polysaccharides belonging to the glucan shell. Image acquisition was performed with an Olympus BH2 microscope, magnification 10, 20 and 40x. Immunofluorescence techniques were exploited to visualize monocytes/macrophages in regions of inflammation and 5 investigate co-localization with Cy5-(C16) 2 /Rho labeled Glucan Particles. Macrophages/monocytes were stained by means of a rat antimouse F4/80 antibody, clone CI:A3-1 (AbD Serotec). To obtain antigen retrieval, sections were put into sodium citrate 10 mM 10 buffer solution at pH 6.0, and then heated into a microwave oven at full power for 60 s followed by 9 min in defrost modality. Sections were allowed to cool for 30 min and then rinsed in Tris-Buffered Saline (TBS) for 10 min. Serum blocking was performed with 10 % goat serum (Invitrogen), 60 min. Overnight 15 incubation with the primary antibody rat anti-mouse F4/80 10 µg/mL in blocking solution was performed in a humidified chamber. Blocking solution was used as control. The day after, sections were washed in TBS and incubated 1h at room temperature with the Alexa Fluor® 647 Goat Anti-Rat IgG (H+L) 20 secondary antibody (Life Technologies) diluted 1:500 in blocking solution. After profuse washing in TBS, sections were stained for 10 min with Hoechst 8x10 -5 mg/mL in TBS, rinsed in distilled water, mounted with Fluoroshield TM Mounting Medium and imaged through confocal microscope, magnification 20x (laser 1 25 excitation 405 nm, acquisition window 415-485 nm, laser 2 excitation 458 nm, acquisition window 500-544 nm, laser 3 excitation 633 nm, acquisition window 648-798 nm, to visualize Hoechst, Rhodamine, and the secondary antibody, respectively). 30 
Results and discussion
Amphiphilic dyes Cy5-(C16) 2 and Rhodamine-DOPE (Rho-DOPE, Chart 1) were loaded in the inner core of GPs through a sudden change in solvent polarity. 35 40 Chart 1. Structural formulas of the two amphiphilic dyes entrapped in Glucan Particles. Left: Cy5-(C16)2, right: Rho-DOPE. 45 Briefly, the procedure relied upon the addition of HEPES isotonic buffer to a chloroform suspension containing GPS and the amphiphilic fluorescent molecules previously incubated overnight. Following the change in polarity, a microemulsion 50 containing the amphiphiles formed either outside or inside the particles. The external fraction was removed by repeated washing/centrifugation cycles to obtain the GPs entrapping the fluorescent dyes. The loading was stable for at least one month at 4°C. Morphology and surface properties of modified Glucan 55 Particles (Cy5-(C16) 2 /Rho-GPs) have been investigated by AFM. Particles with diameters in the 3-5.5 μm range (with a mean size of 4.4 ± 0.2 m), were detected. The particle wall structure, as an interwoven network of β-glucan (see ESI †), well corroborates with the atomic structure imaged by STM. 59 Fluorescence 60 confocal microscopy demonstrated the occurred internalization and co-localization of the two fluorescent dyes inside GPs cores (Figure 1) . The DLE was about 72 % for Rho-DOPE, with an estimated concentration of 550±15 pmol/mg, and 62 % for Cy5-(C16) 2 with an estimated concentration of 460±15 pmol/mg GPs, 65 respectively (corresponding to 3.7x10 6 Rho-DOPE molecules/GP and 3.1x10 6 Cy5-(C16) 2 molecules/GP). DLC attested to around 0.06 % and 0.07% for Cy5-(C16) 2 and Rho-DOPE, respectively. The sensitivity in the NIRF detection of GPs loaded with Cy5-(C16) 2 was assessed by preparing a phantom containing solutions 70 at different particles concentrations starting from 18x10 6 GPs/µL (45 µM of Cy5-(C16) 2 ) down to 3.5x10 4 GPs/µL (87.5 nM). The image reported in Figure 2 shows that a detection limit of ca. 70000 particles/µL (175 nM of Cy5-(C16) 2 ) was obtained. Then, the cytotoxicity of fluorescently labelled GPs was 75 determined using J774.A1 murine macrophages, taken as example of phagocytic cells. To that purpose, different amounts of labelled GPs, between 0 and 2.7x10 6 GPs/µL of medium, were incubated for 90 min in the presence of about 2 million phagocytic cells. 
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Cell viability was very high, being comprised between 90% and 100 %, even at the highest concentration. The uptake efficiency of Cy5-(C16) 2 /Rho-GPs by macrophages was analysed by confocal microscopy and FACS (see ESI †). In 5 addition, to define the minimum number of Cy5-(C16) 2 /Rho-GPs labeled monocytes/macrophages detectable by OI, 10 millions of cells were incubated with 3x10 9 Cy5-(C16) 2 /Rho-GPs suspended in 5 mL of complete medium corresponding to 3.20 μM of Cy5-(C16) 2. After 90 min of incubation, cells were washed in PBS, 10 harvested using a cell scraper, and counted. Then, cells were diluted with PBS and imaged in vitro by NIRF. The image reported in Figure 3 indicates that the sample containing 300 cells/µL was still detectable, thus representing an in vitro detection limit of the herein presented labeling method under the 15 experimental conditions described above. In vitro detection limit of the same order of magnitude was reported in literature for cells labeled with NIRF fluorophores. 60
To validate the proposed approach, in vivo NIRF imaging of arthritic joints of the mice enrolled in the study was carried out. 20 Collagen-induced rheumatoid arthritis animal model (DBA-1J strain) was obtained by intra-dermal injection of type II collagen with complete Freund's adjuvant. Three weeks post-injection, erythema and swelling of joints and digits were observed. Then, both diseased and naïve mice were i.v. injected (tail vein) with a 25 suspension of Cy5-(C16) 2 /Rho-GPs containing 9 millions of fluorescent β-glucan particles/µl (corresponding to 0.22 μmol of Cy5-(C16) 2 /kg bw) for in vivo NIRF imaging analysis. Mice were scanned at 5 min, 1 h, 3 h, 5 h, 24 h, and 48 h post injection, and a qualitative in vivo image analysis was performed on each group 30 of mice. The mice were grouped according to the clinical score index value. For each animal, a region of interest was automatically drawn around the inflamed paw. The pixels included in the shape were considered with equal intensity and the threshold intensity value at which the shape was drawn was 35 calculated as follows:
Threshold Intensity Value= Background Mean + (Background Standard Deviation X Standard Deviation Multiplier)
A total mean intensity signal (in Relative Fluorescence Unit -RFU-) was measured over time (post 5 min, 1 hr, 3 hrs, 5 hrs, 24 40 hrs and 48 hrs) for the four paws of each animal in both frontal and ventral sides. The average of these values, including the animals with different clinical score, was compared with the signal intensity obtained from the analysis of naïve mice. The fluorescence intensity signal in the inflamed paws was higher 45 than the corresponding value measured for the naïve mice. A statistically significant difference was observed 3 h post injection (1.7±0.1 vs. 1.3±0.1; P< 0.05, Figure 4 ). The short time requested for the detection of the maximum signal in the lesion is likely the result of a fast uptake by blood 95 monocytes. This finding parallels well with the very rapid uptake of GPs (ca 1 h) reported in vitro by J774.A1 macrophages. 42 Figure 6 indicates that the % enhancement of fluorescence signal intensity (in RFU) calculated at 3 hrs post injection displayed a good correlation with the severity of the lesion expressed 100 according to the values of the clinical score index. One peculiarity of the CIA model is due to the remission of the pathology that usually occurs within thirty days. 61 In order to assess if the imaging response could depend on the phase 15 (progression or remitting) of the inflammation process, the fluorescence signal of mice having the same clinical score value (4.5), but in ascending, stable, or descending trend, were compared. The result is shown in Figure 7 . Very interestingly, it was possible to detect subtle variations in the imaging response. 20 Animals with an increasing score index displayed a higher signal. Such animals were supposedly into a state of joints bursting inflammation, where the degree of monocyte infiltration was extremely high. On the other hand, the lower signal observed for the animals with a descending score index was correlated to the 25 remitting state of the inflammation, characterized by a far lower tissue degradation and infiltration of immune cells. 62 To characterize the arthritic model obtained and prove GPs recruitment in inflamed regions, histological studies were carried out. Cryopreserved paws from naïve and CIA-affected DBA/1J 30 mice were cut through a cryostat. The slices obtained underwent H&E staining to investigate the presence of phagocytic cells in the inflamed regions. In CIA mice, H&E staining highlighted the high degree of inflammation, which was mainly located in the periarticular region, associated with diffuse hemorrhage and 35 widespread edema (Figure 8) . Conversely, the phagocytic population in naïve mice was not relevant and neither edema nor hemorrhage were detected. In arthritic mice, PAS staining highlighted the presence of GPs in the periarticular region, as well as in blood vessels and in arthritic paws, mainly associated with phagocytic cells (Figure 9 ). 55 By fluorescence confocal microscopy, it was possible to appreciate the localization of Cy5-(C16) 2 /Rho GPs (red) in the periarticular region, while in naïve mice no GPs were detected ( Figure 10 ). Monocytes/macrophages were stained by anti-F4/80 antibody with the purpose of proving the presence of immune 60 cells and their co-localization with GPs. F4/80 is a wellcharacterized and extensively referenced membrane protein that is likely the best-known marker for mature mouse macrophages and blood monocytes. 63 Unfortunately, F4/80 staining was not perfectly clear, probably due to antigen damage following the 65 procedure of decalcification. Moreover, the emission wavelength of secondary antibody and Cy5-(C16) 2 partially overlapped. Therefore, the result was the observation of a diffuse signal around glucan particles, owing to weak bond of the antibody, combined with bright spots corresponding to GPs content. In 70 naïve mice, neither inflammation nor GPs recruitment were detected. 
Conclusions
In this study, the diagnostic potential of Glucan Particles loaded 10 with an amphiphilic NIRF agent to detect inflammation sites was successfully tested on a murine model of collagen-induced arthritis. It has been demonstrated that the NIRF signal detected in the inflammation paws arose from the infiltration of blood monocytes/macrophages labeled after the systemic administration 15 of the GPs. The goodness of the rationale of using highly biocompatible microcarriers for targeting the cellular infiltration in inflammation, without the extravasation of the untargeted agent, was validated by ex-vivo histology, which confirmed that the presence of labeled macrophages in the lesion was the result 20 of the rapid uptake of the particles by circulating immune cells. Importantly, in addition to the good correlation with the clinical score of the disease, the fluorescence imaging response allowed to discriminate between animals with a progressive or remitting phase of the pathology. The results presented in this work 25 highlight the clinical potential of Glucan Particles either as diagnostic agents or as therapeutic carriers. The possibility to entrap both the diagnostic and the therapeutic companions in the same carrier could allow the design of theranostic procedures where the imaging probe would provide information about both 30 the effective delivery of the drug and its therapeutic effects. 
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